CN110628042B - 荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 - Google Patents
荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 Download PDFInfo
- Publication number
- CN110628042B CN110628042B CN201911038918.4A CN201911038918A CN110628042B CN 110628042 B CN110628042 B CN 110628042B CN 201911038918 A CN201911038918 A CN 201911038918A CN 110628042 B CN110628042 B CN 110628042B
- Authority
- CN
- China
- Prior art keywords
- zif
- fluorescence
- gsh
- imidazolate framework
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 139
- 238000002360 preparation method Methods 0.000 title claims abstract description 109
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 89
- 239000002184 metal Substances 0.000 title claims abstract description 89
- 229910021536 Zeolite Inorganic materials 0.000 title claims abstract description 69
- 239000010457 zeolite Substances 0.000 title claims abstract description 69
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 title claims abstract description 66
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 title claims abstract description 66
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 65
- 239000000463 material Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000010931 gold Substances 0.000 claims description 119
- 239000013154 zeolitic imidazolate framework-8 Substances 0.000 claims description 109
- MFLKDEMTKSVIBK-UHFFFAOYSA-N zinc;2-methylimidazol-3-ide Chemical compound [Zn+2].CC1=NC=C[N-]1.CC1=NC=C[N-]1 MFLKDEMTKSVIBK-UHFFFAOYSA-N 0.000 claims description 109
- 239000011701 zinc Substances 0.000 claims description 25
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 19
- 239000003446 ligand Substances 0.000 claims description 16
- -1 zeolite imidazole ester Chemical class 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 229960003180 glutathione Drugs 0.000 claims description 12
- 229910021645 metal ion Inorganic materials 0.000 claims description 11
- YAGCJGCCZIARMJ-UHFFFAOYSA-N N1C(=NC=C1)C=O.[Zn] Chemical compound N1C(=NC=C1)C=O.[Zn] YAGCJGCCZIARMJ-UHFFFAOYSA-N 0.000 claims description 10
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 10
- 230000006798 recombination Effects 0.000 claims description 7
- 238000005215 recombination Methods 0.000 claims description 7
- 238000003384 imaging method Methods 0.000 claims description 6
- 102100029880 Glycodelin Human genes 0.000 claims description 5
- 101000585553 Homo sapiens Glycodelin Proteins 0.000 claims description 5
- 239000013167 zeolitic imidazolate framework-1 Substances 0.000 claims description 5
- 239000013165 zeolitic imidazolate framework-100 Substances 0.000 claims description 5
- 239000013168 zeolitic imidazolate framework-2 Substances 0.000 claims description 5
- 239000013169 zeolitic imidazolate framework-3 Substances 0.000 claims description 5
- 239000013155 zeolitic imidazolate framework-4 Substances 0.000 claims description 5
- 239000013170 zeolitic imidazolate framework-5 Substances 0.000 claims description 5
- 239000013171 zeolitic imidazolate framework-6 Substances 0.000 claims description 5
- 239000013156 zeolitic imidazolate framework-62 Substances 0.000 claims description 5
- 239000013158 zeolitic imidazolate framework-68 Substances 0.000 claims description 5
- 239000013159 zeolitic imidazolate framework-69 Substances 0.000 claims description 5
- 239000013160 zeolitic imidazolate framework-70 Substances 0.000 claims description 5
- 239000013161 zeolitic imidazolate framework-78 Substances 0.000 claims description 5
- 239000013162 zeolitic imidazolate framework-81 Substances 0.000 claims description 5
- 239000013163 zeolitic imidazolate framework-82 Substances 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000013174 zeolitic imidazolate framework-10 Substances 0.000 claims description 4
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 3
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 claims description 3
- 108010024636 Glutathione Proteins 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
- 229960001639 penicillamine Drugs 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 230000002860 competitive effect Effects 0.000 claims description 2
- 230000009881 electrostatic interaction Effects 0.000 claims description 2
- 150000002460 imidazoles Chemical class 0.000 claims description 2
- 230000002776 aggregation Effects 0.000 abstract description 6
- 238000004220 aggregation Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 16
- 238000009210 therapy by ultrasound Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 11
- 239000013153 zeolitic imidazolate framework Substances 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 6
- 238000004020 luminiscence type Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 5
- 239000012621 metal-organic framework Substances 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 4
- 229910004042 HAuCl4 Inorganic materials 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 3
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000634 powder X-ray diffraction Methods 0.000 description 3
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- XIOUDVJTOYVRTB-UHFFFAOYSA-N 1-(1-adamantyl)-3-aminothiourea Chemical compound C1C(C2)CC3CC2CC1(NC(=S)NN)C3 XIOUDVJTOYVRTB-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002082 metal nanoparticle Substances 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- WGYFINWERLNPHR-UHFFFAOYSA-N 3-nitroanisole Chemical compound COC1=CC=CC([N+]([O-])=O)=C1 WGYFINWERLNPHR-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 101150113720 aunc gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/008—Supramolecular polymers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/188—Metal complexes of other metals not provided for in one of the previous groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Nanotechnology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Luminescent Compositions (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911038918.4A CN110628042B (zh) | 2019-10-29 | 2019-10-29 | 荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911038918.4A CN110628042B (zh) | 2019-10-29 | 2019-10-29 | 荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110628042A CN110628042A (zh) | 2019-12-31 |
CN110628042B true CN110628042B (zh) | 2022-03-22 |
Family
ID=68978271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911038918.4A Expired - Fee Related CN110628042B (zh) | 2019-10-29 | 2019-10-29 | 荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110628042B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111320697A (zh) * | 2020-02-13 | 2020-06-23 | 江苏大学 | 一种酶标二抗HRP/羊抗鼠IgG@ZIF-L及其制备方法和应用 |
CN111423876B (zh) * | 2020-05-08 | 2023-12-29 | 无锡市疾病预防控制中心 | 一种具有圆偏振发光的银硫纳米簇聚集体的制备方法 |
CN112190767B (zh) * | 2020-09-22 | 2022-07-26 | 上海市第六人民医院 | 一种基于纳米金团簇的纳米抗菌涂层材料及其制备方法 |
CN111961462B (zh) * | 2020-09-23 | 2022-06-03 | 南宁师范大学 | Zif-8包覆的金纳米簇材料及其制备方法和应用 |
CN112362646B (zh) * | 2020-10-27 | 2022-04-22 | 华南理工大学 | 一种基于纳米酶的谷胱甘肽传感器及其制备方法与应用 |
CN113621362B (zh) * | 2021-07-02 | 2023-07-07 | 济南大学 | Zif-8包裹发光型多酸复合材料的制备方法及硫离子检测应用 |
CN114062333A (zh) * | 2021-10-09 | 2022-02-18 | 华南农业大学 | Zif-8包覆金纳米簇复合材料的应用、有机磷的检测方法 |
CN116948634A (zh) * | 2023-07-25 | 2023-10-27 | 曲阜师范大学 | 温度响应型发光mof及其制备方法和应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108555311A (zh) * | 2018-04-18 | 2018-09-21 | 北京化工大学 | 一种构晶离子诱导生长将金属纳米团簇嵌入金属有机骨架材料的方法 |
CN109991201A (zh) * | 2019-04-11 | 2019-07-09 | 大连理工大学 | 一种定位在zif-8表面的金纳米簇用于提高其荧光强度及检测的特异选择性的方法 |
-
2019
- 2019-10-29 CN CN201911038918.4A patent/CN110628042B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108555311A (zh) * | 2018-04-18 | 2018-09-21 | 北京化工大学 | 一种构晶离子诱导生长将金属纳米团簇嵌入金属有机骨架材料的方法 |
CN109991201A (zh) * | 2019-04-11 | 2019-07-09 | 大连理工大学 | 一种定位在zif-8表面的金纳米簇用于提高其荧光强度及检测的特异选择性的方法 |
Non-Patent Citations (3)
Title |
---|
Fabrication of Au25(SG)18-ZIF-8 Nanocomposites: A Facile Strategy to Position Au25(SG)18 Nanoclusters Inside and Outside ZIF-8;Yucheng Luo等;《advanced materials》;20171222;第30卷(第6期);第1704576(2/9)页右栏第1段、第1704576(7/9)页右栏第2段 * |
Photoluminescence light-up detection of zinc ion and imaging in living cellsbased on the aggregation induced emission enhancement of glutathionecappedcopper nanoclusters;Liyun Lin等;《Biosensors and Bioelectronics》;20170319;第94卷;第527页右栏第3.4部分 * |
Yucheng Luo等.Fabrication of Au25(SG)18-ZIF-8 Nanocomposites: A Facile Strategy to Position Au25(SG)18 Nanoclusters Inside and Outside ZIF-8.《advanced materials》.2017,第30卷(第6期), * |
Also Published As
Publication number | Publication date |
---|---|
CN110628042A (zh) | 2019-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110628042B (zh) | 荧光增强型金属纳米团簇/沸石咪唑酯骨架复合纳米材料的制备方法及其应用 | |
US10421901B2 (en) | Preparation method of near-infrared silver sulfide quantum dots | |
Li et al. | Fluorescence enhancement for noble metal nanoclusters | |
Shang et al. | Facile preparation of water-soluble fluorescent gold nanoclusters for cellular imaging applications | |
Liu et al. | One-pot synthesis of ternary CuInS 2 quantum dots with near-infrared fluorescence in aqueous solution | |
Li et al. | Engineering the self-assembly induced emission of copper nanoclusters as 3D nanomaterials with mesoporous sphere structures by the crosslinking of Ce3+ | |
Liu et al. | Highly selective phosphorescent nanoprobes for sensing and bioimaging of homocysteine and cysteine | |
CN103464780A (zh) | 一种鸡卵清蛋白稳定的荧光金纳米簇的制备方法 | |
US20120329998A1 (en) | Luminescent gold nanoparticle functionalized by n-(4-aminobutyl)-n-ethylisoluminol, preparation and application thereof | |
CN107470648B (zh) | 一种dna功能化金纳米团簇及其制备方法 | |
EP2527346A1 (en) | Photoluminescent nanoparticle, preparation, and application thereof | |
Zhao et al. | The synthesis of metal nanoclusters and their applications in bio-sensing and imaging | |
DK2830795T3 (en) | NANOAG DEGREES OF MOLECULAR ULTRASMY CLINDS OF PRECIOUS METALS AND A PROCEDURE FOR THE PRODUCTION THEREOF | |
CN104745193B (zh) | 一种荧光磁性纳米复合材料及其制备方法 | |
KR101749805B1 (ko) | 란타나이드 금속착제 및 실리콘이 포함된 수용성 고분자로 코팅된 형광나노입자 제조방법 | |
JP6164637B2 (ja) | 生体試料標識用蛍光プローブ | |
Baghdasaryan et al. | Facile synthesis, size-separation, characterization, and antimicrobial properties of thiolated copper clusters | |
CN109705840A (zh) | 基于亲和组装的高发光量子点荧光微球的制备方法 | |
CN101905328B (zh) | 一种水溶性Au10纳米团簇分子的制备方法 | |
CN111423878A (zh) | 一种荧光磁性复合纳米颗粒、其制备方法以及由该荧光磁性复合纳米颗粒制备的生物探针 | |
Wang et al. | Highly luminescent CuInS 2–ZnS nanocrystals: achieving phase transfer and nuclear homing property simultaneously through simple TTAB modification | |
Huo et al. | Aggregation induced emission of amino-thiol capped gold nanoparticles (GNPs) through metal-amino-coordination | |
CN110724519B (zh) | 基于超分子大环的荧光增强型金纳米团簇复合材料的制备方法及其应用 | |
Wang et al. | Fabrication of hybridized nanoparticles with aggregation-induced emission characteristics and application for cell imaging | |
Ma et al. | A microemulsion preparation of nanoparticles of europium in silica with luminescence enhancement using silver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220218 Address after: 710072 No. 127 Youyi West Road, Shaanxi, Xi'an Applicant after: Northwestern Polytechnical University Applicant after: RESEARCH & DEVELOPMENT INSTITUTE OF NORTHWESTERN POLYTECHNICAL University IN SHENZHEN Address before: 518057 room a311, Virtual University Park, No. 19, Gaoxin South 4th Road, Science Park, Nanshan District, Shenzhen, Guangdong Province Applicant before: RESEARCH & DEVELOPMENT INSTITUTE OF NORTHWESTERN POLYTECHNICAL University IN SHENZHEN |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220322 |